Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 129

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 129
---
 the shares of Series A Preferred Stock set forth in clause (i), (iii) the conversion of 213 shares of Series B Preferred Stock into 41,376 shares of Common Stock, and (iv) the issuance of 436,383 shares of Common Stock pursuant to the Keystone Equity Financing, in each case from October 1, 2024 through January 8, 2025, our as adjusted net tangible book would have been $357,000 or $0.13 per share of Common Stock. After giving effect to the receipt of the net proceeds from our sale of Common Stock in this offering at an assumed public offering price of $2.00 per share of Common Stock, assuming no sale of Pre-Funded Warrants in this offering and no exercise of Offered Common Warrants and after deducting placement agent fees and estimated offering expenses payable by us, our pro forma net tangible book value as of September 30, 2024, would have been $1.07 per share of Common Stock. This represents an immediate increase in net tangible book value of $0.94 per share of Common Stock to our existing shareholders compared to our as adjusted net tangible book value per share and immediate dilution in net tangible assets per share of $0.93 per share of Common Stock to investors purchasing Common Stock in this offering on such basis. The following table illustrates this dilution on a per share of Common Stock basis, assuming all shares of common stock outstanding as of September 30, 2024:

| Assumed public offering price per share of Common Stock                                    
 Historical net tangible book value per share of Common Stock as of September               
 30, 2024                                                                                   |     |   | (2.48 | ) |     |   |  2.00 |   |
|:-------------------------------------------------------------------------------------------|:----|:--|------:|:--|:----|:--|------:|:--|
| Increase (decrease) in net tangible                                                        
 book value per share of Common Stock resulting from subsequent transactions                |     |   |  2.61 |   |     |   |       |   |
| As adjusted net tangible book value                                                        
 per share of Common Stock as of September 30, 2024                                         |     |   |  0.13 |   |     |   |       |   |
| Increase in net tangible book value                                                        
 per share of Common Stock attributed to investors purchasing Common Stock in this offering |     | $ |